drugset / Trial / NCT04408144
Addition of Dydrogesterone to the Luteal Phase Support After Fresh Embryo Transfer
RandomizedParallel-groupOpen-labelTreatment
Summary
Randomized controlled study, open label to compare effectiveness of addition of dydrogesterone 20mg to the standard luteal phase support treatment after fresh embryos transfer.
Timeline
- Start
- 2022-04-01
- Primary completion
- 2022-05-31
- Completion
- 2023-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dydrogesterone | Other / unclassified | 10 mg | Oral |